IL-1 induces proinflammatory leukocyte infiltration and regulates fibroblast phenotype in the infarcted myocardium

Journal of Immunology

Volumn 191, Issue 9, 2013, Pages 4838-4848

  Saxena, Amit ^a   Chen, Wei ^a   Su, Ya ^a   Rai, Vikrant ^a   Uche, Olisambu U ^a   Li, Na ^a   Frangogiannis, Nikolaos G ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BONE MORPHOGENETIC PROTEIN AND ACTIVIN MEMBRANE BOUND INHIBITOR; ENDOGLIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 1 RECEPTOR TYPE II; INTERLEUKIN 1BETA; NEUTROPHIL COLLAGENASE; REGULATOR PROTEIN; STROMELYSIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; CD11B ANTIGEN; CHEMOKINE; CYTOKINE; IL1R1 PROTEIN, MOUSE; LY ANTIGEN; LY-6C ANTIGEN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; ENZYME SYNTHESIS; FEMALE; FIBROBLAST; FLOW CYTOMETRY; HEART INFARCTION; LEUKOCYTE MIGRATION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL MOTION; DEFICIENCY; GENETICS; HEART FAILURE; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; METABOLISM; NEUTROPHIL CHEMOTAXIS; WOUND HEALING;

ANIMALS; ANTIGENS, CD11B; ANTIGENS, LY; CELL MOVEMENT; CHEMOKINES; CYTOKINES; FEMALE; HEART FAILURE; INFLAMMATION; INTERLEUKIN-1; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; NEUTROPHIL INFILTRATION; RECEPTORS, INTERLEUKIN-1 TYPE I; RECEPTORS, INTERLEUKIN-1 TYPE II; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 84886042230     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300725     Document Type: Article

References (42)

1. Dinarello, C. A. 2011. A clinical perspective of IL-1β as the gatekeeper of inflammation. Eur. J. Immunol. 41: 1203-1217.
2. Dinarello, C. A., A. Simon, and J. W. van der Meer. 2012. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat. Rev. Drug Discov. 11: 633-652.
3. Bujak, M., and N. G. Frangogiannis. 2009. The role of IL-1 in the pathogenesis of heart disease. Arch. Immunol. Ther. Exp. (Warsz.) 57: 165-176.
4. Denes, A., C. Drake, J. Stordy, J. Chamberlain, B. W. McColl, H. Gram, D. Crossman, S. Francis, S. M. Allan, and N. J. Rothwell. 2012. Interleukin-1 mediates neuroinflammatory changes associated with diet-induced atherosclerosis. J Am Heart Assoc 1: e002006.
5. Ridker, P. M., T. Thuren, A. Zalewski, and P. Libby. 2011. Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS). Am. Heart J. 162: 597-605.
6. Dewald, O., G. Ren, G. D. Duerr, M. Zoerlein, C. Klemm, C. Gersch, S. Tincey, L. H. Michael, M. L. Entman, and N. G. Frangogiannis. 2004. Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction. Am. J. Pathol. 164: 665-677.
7. Bujak, M., M. Dobaczewski, K. Chatila, L. H. Mendoza, N. Li, A. Reddy, and N. G. Frangogiannis. 2008. Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. Am. J. Pathol. 173: 57-67.
8. Abbate, A., F. N. Salloum, E. Vecile, A. Das, N. N. Hoke, S. Straino, G. G. BiondiZoccai, J. E. Houser, I. Z. Qureshi, E. D. Ownby, et al. 2008. Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction. Circulation 117: 2670-2683.
9. Haudek, S. B., G. E. Taffet, M. D. Schneider, and D. L. Mann. 2007. TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways. J. Clin. Invest. 117: 2692-2701.
10. Schulz, R., D. L. Panas, R. Catena, S. Moncada, P. M. Olley, and G. D. Lopaschuk. 1995. The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumour necrosis factor-alpha. Br. J. Pharmacol. 114: 27-34.
11. Li, Y. Y., Y. Q. Feng, T. Kadokami, C. F. McTiernan, R. Draviam, S. C. Watkins, and A. M. Feldman. 2000. Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by antitumor necrosis factor alpha therapy. Proc. Natl. Acad. Sci. USA 97: 12746-12751.
12. Kurrelmeyer, K. M., L. H. Michael, G. Baumgarten, G. E. Taffet, J. J. Peschon, N. Sivasubramanian, M. L. Entman, and D. L. Mann. 2000. Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc. Natl. Acad. Sci. USA 97: 5456-5461.
13. Hamid, T., Y. Gu, R. V. Ortines, C. Bhattacharya, G. Wang, Y. T. Xuan, and S. D. Prabhu. 2009. Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor-kappaB and inflammatory activation. Circulation 119: 1386-1397.
14. Mann, D. L., J. J. McMurray, M. Packer, K. Swedberg, J. S. Borer, W. S. Colucci, J. Djian, H. Drexler, A. Feldman, L. Kober, et al. 2004. Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation 109: 1594-1602.
15. Abbate, A., M. C. Kontos, J. D. Grizzard, G. G. Biondi-Zoccai, B. W. Van Tassell, R. Robati, L. M. Roach, R. A. Arena, C. S. Roberts, A. Varma, et al.; VCU-ART Investigators. 2010. Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study). Am J Cardiol. 105: 1371-1377.e1.
16. Labow, M., D. Shuster, M. Zetterstrom, P. Nunes, R. Terry, E. B. Cullinan, T. Bartfai, C. Solorzano, L. L. Moldawer, R. Chizzonite, and K. W. McIntyre. 1997. Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice. J. Immunol. 159: 2452-2461.
17. Dobaczewski, M., Y. Xia, M. Bujak, C. Gonzalez-Quesada, and N. G. Frangogiannis. 2010. CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells. Am. J. Pathol. 176: 2177-2187.
18. Bujak, M., M. Dobaczewski, C. Gonzalez-Quesada, Y. Xia, T. Leucker, P. Zymek, V. Veeranna, A. M. Tager, A. D. Luster, and N. G. Frangogiannis. 2009. Induction of the CXC chemokine interferon-gamma-inducible protein 10 regulates the reparative response following myocardial infarction. Circ. Res. 105: 973-983.
19. Dobaczewski, M., M. Bujak, N. Li, C. Gonzalez-Quesada, L. H. Mendoza, X. F. Wang, and N. G. Frangogiannis. 2010. Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction. Circ. Res. 107: 418-428.
20. Nahrendorf, M., F. K. Swirski, E. Aikawa, L. Stangenberg, T. Wurdinger, J. L. Figueiredo, P. Libby, R. Weissleder, and M. J. Pittet. 2007. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 204: 3037-3047.
21. Frangogiannis, N. G. 2012. Matricellular proteins in cardiac adaptation and disease. Physiol. Rev. 92: 635-688.
22. Oka, T., J. Xu, R. A. Kaiser, J. Melendez, M. Hambleton, M. A. Sargent, A. Lorts, E. W. Brunskill, G. W. Dorn, II, S. J. Conway, et al. 2007. Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ. Res. 101: 313-321.
23. Dewald, O., P. Zymek, K. Winkelmann, A. Koerting, G. Ren, T. Abou-Khamis, L. H. Michael, B. J. Rollins, M. L. Entman, and N. G. Frangogiannis. 2005. CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ. Res. 96: 881-889.
24. Colotta, F., F. Re, M. Muzio, R. Bertini, N. Polentarutti, M. Sironi, J. G. Giri, S. K. Dower, J. E. Sims, and A. Mantovani. 1993. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261: 472-475.
25. Colotta, F., S. K. Dower, J. E. Sims, and A. Mantovani. 1994. The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1. Immunol. Today 15: 562-566.
26. Saccani, S., N. Polentarutti, G. Penton-Rol, J. E. Sims, and A. Mantovani. 1998. Divergent effects of LPS on expression of IL-1 receptor family members in mononuclear phagocytes in vitro and in vivo. Cytokine 10: 773-780.
27. O'Neill, L. A. 2008. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol. Rev. 226: 10-18.
28. McGillicuddy, F. C., K. A. Harford, C. M. Reynolds, E. Oliver, M. Claessens, K. H. Mills, and H. M. Roche. 2011. Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis. Diabetes 60: 1688-1698.
29. Gasse, P., C. Mary, I. Guenon, N. Noulin, S. Charron, S. Schnyder-Candrian, B. Schnyder, S. Akira, V. F. Quesniaux, V. Lagente, et al. 2007. IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice. J. Clin. Invest. 117: 3786-3799.
30. Pineau, I., L. Sun, D. Bastien, and S. Lacroix. 2010. Astrocytes initiate inflammation in the injured mouse spinal cord by promoting the entry of neutrophils and inflammatory monocytes in an IL-1 receptor/MyD88-dependent fashion. Brain Behav. Immun. 24: 540-553.
31. Graves, D. T., N. Nooh, T. Gillen, M. Davey, S. Patel, D. Cottrell, and S. Amar. 2001. IL-1 plays a critical role in oral, but not dermal, wound healing. J. Immunol. 167: 5316-5320.
32. Souders, C. A., S. L. Bowers, and T. A. Baudino. 2009. Cardiac fibroblast: the renaissance cell. Circ. Res. 105: 1164-1176.
33. Smith, R. S., T. J. Smith, T. M. Blieden, and R. P. Phipps. 1997. Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am. J. Pathol. 151: 317-322.
34. Chen, W., and N. G. Frangogiannis. 2013. Fibroblasts in post-infarction inflammation and cardiac repair. Biochim. Biophys. Acta 1833: 945-953.
35. Kawaguchi, M., M. Takahashi, T. Hata, Y. Kashima, F. Usui, H. Morimoto, A. Izawa, Y. Takahashi, J. Masumoto, J. Koyama, et al. 2011. Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation 123: 594-604.
36. Willems, I. E., M. G. Havenith, J. G. De Mey, and M. J. Daemen. 1994. The alpha-smooth muscle actin-positive cells in healing human myocardial scars. Am. J. Pathol. 145: 868-875.
37. Cleutjens, J. P., M. J. Verluyten, J. F. Smiths, and M. J. Daemen. 1995. Collagen remodeling after myocardial infarction in the rat heart. Am. J. Pathol. 147: 325-338.
38. Birdsall, H. H., D. M. Green, J. Trial, K. A. Youker, A. R. Burns, C. R. MacKay, G. J. LaRosa, H. K. Hawkins, C. W. Smith, L. H. Michael, et al 1997. Complement C5a, TGF-beta 1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion. Circulation 95: 684-692.
39. Frangogiannis, N. G., L. H. Michael, and M. L. Entman. 2000. Myofibroblasts in reperfused myocardial infarcts express the embryonic form of smooth muscle myosin heavy chain (SMemb). Cardiovasc. Res. 48: 89-100.
40. Kapur, N. K., S. Wilson, A. A. Yunis, X. Qiao, E. Mackey, V. Paruchuri, C. Baker, M. J. Aronovitz, S. A. Karumanchi, M. Letarte, et al. 2012. Reduced endoglin activity limits cardiac fibrosis and improves survival in heart failure. Circulation 125: 2728-2738.
41. Onichtchouk, D., Y. G. Chen, R. Dosch, V. Gawantka, H. Delius, J. Massagué, and C. Niehrs. 1999. Silencing of TGF-beta signalling by the pseudoreceptor BAMBI. Nature 401: 480-485.
42. Villar, A. V., R. García, M. Llano, M. Cobo, D. Merino, A. Lantero, M. Tramullas, J. M. Hurlé, M. A. Hurlé, and J. F. Nistal. 2013. BAMBI (BMP and activin membrane-bound inhibitor) protects the murine heart from pressureoverload biomechanical stress by restraining TGF-β signaling. Biochim. Biophys. Acta 1832: 323-335.